Bexarotene in Treating Patients With Metastatic Breast Cancer
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to study the effectiveness of bexarotene in treating patients who have metastatic breast cancer.
Key facts
- Study ID
- NCT00003752
- Run by
- Ligand Pharmaceuticals
- People needed
- 180
- Starts
- 1998-10-01
- Expected to finish
- 2003-03-01
- Last updated by the study team
- 2013-05-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama Comprehensive Cancer Center — Birmingham, Alabama, United States
- Arizona Cancer Center — Tucson, Arizona, United States
- University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
- Beckman Research Institute, City of Hope — Los Angeles, California, United States
- Kaiser Permanente-Southern California Permanente Medical Group — San Diego, California, United States
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- Yale Comprehensive Cancer Center — New Haven, Connecticut, United States
- Vincent T. Lombardi Cancer Research Center, Georgetown University — Washington D.C., District of Columbia, United States
- Baptist Regional Cancer Institute - Jacksonville — Jacksonville, Florida, United States
- Mayo Clinic Jacksonville — Jacksonville, Florida, United States
- Sylvester Cancer Center, University of Miami — Miami, Florida, United States
- Cancer Research Center of Hawaii — Honolulu, Hawaii, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
- Louisiana State University School of Medicine — New Orleans, Louisiana, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Michigan State University — East Lansing, Michigan, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- Arthur G. James Cancer Hospital - Ohio State University — Columbus, Ohio, United States
- Hematology Oncology Consultants Inc — Columbus, Ohio, United States
- Oregon Cancer Center at Oregon Health Sciences University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.